🇺🇸 Vonoprazan triple therapy in United States

Vonoprazan triple therapy (Vonoprazan triple therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Vonoprazan triple therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Vonoprazan triple therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Vonoprazan triple therapy in United States?

Alexandria University is the originator. The local marketing authorisation holder may differ — check the official source linked above.